Tuesday, 31 May 2011

Delhistine D


Generic Name: pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine (fen IR a meen/pie RILL a meen/fen ill toe LOX a meen/fen ill proe pa NOLE a meen)

Brand Names: Delhist D, Delhistine D, Histine-D, Iohist D, KG-Hist D, Liqui-Histine-D, Metahistine D, Multihist D, Multihistamine-D, Poly-D, Poly-Histine-D, Prohistine-D, Trihist-D


What is Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?

Pheniramine, pyrilamine, and phenyltoloxamine are antihistamines. They block the effects of the naturally occurring chemical histamine in the body. Pheniramine, pyrilamine, and phenyltoloxamine prevent sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.


Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow to certain areas and allows nasal and respiratory (breathing) passages to open up.


Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine is used to treat nasal congestion and sinusitis (inflammation of the sinuses) associated with allergies, hay fever, and the common cold.


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Use caution when driving, operating machinery, or performing other hazardous activities. Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking this medication.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.


Who should not take Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?


Do not take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have


  • kidney disease,

  • liver disease,


  • diabetes,




  • glaucoma,




  • any type of heart disease or high blood pressure,




  • thyroid disease,




  • emphysema or chronic bronchitis, or




  • difficulty urinating or an enlarged prostate.



You may not be able to take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine passes into breast milk and may harm a nursing infant. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 65 years of age, you may be more likely to experience side effects from pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?


Take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Do not crush, chew, or break the long-acting or sustained-release forms of this medication. Swallow them whole. If you are unsure about the formulation of the medicine, ask your pharmacist for help.

If you cannot swallow the tablets or capsules, look for a liquid form of this medication.


To ensure that you get a correct dose, measure the liquid form of pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Do not take more of this medication than is recommended. An overdose can cause serious harm.

Do not take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.


Store pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, and vomiting.


What should I avoid while taking Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine.

Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine) side effects


Serious side effects are unlikely to occur. Stop taking pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine and talk to your doctor or try another similar medication if you experience



  • dryness of the eyes, nose, and mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation in children.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Delhistine D (pheniramine/ pyrilamine/ phenyltoloxamine/ phenylpropanolamine)?


Do not take pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain pheniramine, pyrilamine, phenyltoloxamine, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.


Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine is taken with any of these medications.


Drugs other than those listed here may also interact with pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products.



More Delhistine D resources


  • Delhistine D Drug Interactions
  • Delhistine D Support Group
  • 0 Reviews for Delhistine D - Add your own review/rating


Compare Delhistine D with other medications


  • Allergies
  • Eye Dryness/Redness
  • Eye Redness/Itching
  • Hay Fever
  • Nasal Congestion
  • Rhinorrhea
  • Sinusitis
  • Upper Respiratory Tract Infection


Where can I get more information?


  • Your pharmacist has additional information about pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine written for health professionals that you may read.

What does my medication look like?


Pheniramine/pyrilamine/phenyltoloxamine/phenylpropanolamine is available with a prescription under the brand names Poly-Histine-D (capsules and elixir) and Liqui-Histine Elixir. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.



Saturday, 21 May 2011

Pegaspargase




In the US, Pegaspargase (pegaspargase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia.

US matches:

  • Pegaspargase

  • Pegaspargase Intramuscular, Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX24

CAS registry number (Chemical Abstracts Service)

0130167-69-0

Therapeutic Category

Antineoplastic agent

Chemical Names

Asparaginase, reaction product with succinic anhydride, esters with polyethylene glycol monomethyl ether

Poly{N-[alpha-methyl-omega-succinylpoly(oxyethylen)oxy]}sparaginase

Foreign Names

  • Pegaspargasum (Latin)
  • Pegaspargase (German)
  • Pegaspargase (French)
  • Pegaspargasa (Spanish)

Generic Names

  • Pegaspargase (OS: USAN)
  • PEG-L-asparaginase (IS)

Brand Names

  • Oncaspar
    Enzon, United States; Filaxis, Argentina; Medac, Germany; Medac, Poland

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 20 May 2011

Fradiomycin




Fradiomycin may be available in the countries listed below.


Ingredient matches for Fradiomycin



Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Fradiomycin in the following countries:


  • Japan

International Drug Name Search

Tuesday, 17 May 2011

Rituximab




In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Evan's Syndrome, Follicular Lymphoma, Idiopathic Thrombocytopenic Purpura, Microscopic polyangiitis, Non-Hodgkin's Lymphoma, Pemphigoid, Pemphigus, Rheumatoid Arthritis and Wegener's Granulomatosus.

US matches:

  • Rituximab

  • Rituximab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC02

CAS registry number (Chemical Abstracts Service)

0174722-31-7

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Antineoplastic agent, microtubule inhibitor

Biological response modifier, BRM

Immunomodulator

Monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide with human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)

Foreign Names

  • Rituximabum (Latin)
  • Rituximab (German)
  • Rituximab (French)
  • Rituximab (Spanish)

Generic Names

  • Rituximab (OS: BAN, DCF)
  • IDEC 102 (IS: IDEC)
  • IDEC C2B8 (IS: IDEC)

Brand Names

  • MabThera
    Pfizer, France; Roche, United Arab Emirates; Roche, Albania; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Aruba; Roche, Bosnia & Herzegowina; Roche, Bangladesh; Roche, Belgium; Roche, Bahrain; Roche, Brazil; Roche, Belarus; Roche, Switzerland; Roche, Chile; Roche, China; Roche, Colombia; Roche, Cuba; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Dominican Republic; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Finland; Roche, United Kingdom; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, India; Roche, Iraq; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Jordan; Roche, Kuwait; Roche, Kazakhstan; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Morocco; Roche, Macedonia; Roche, Mexico; Roche, Malaysia; Roche, Netherlands; Roche, Norway; Roche, Nepal; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Pakistan; Roche, Poland; Roche, Portugal; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Slovenia; Roche, Slovakia; Roche, Syria; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Ukraine; Roche, Uruguay; Roche, Venezuela; Roche, Yemen; Roche, South Africa; Roche Pharmaceutical, Japan; Roche RX, Singapore


  • Mabthera
    Roche, Sweden


  • Reditux
    Dr Reddys, Vietnam


  • Rituxan
    Biogen, United States; Genentech, United States; Roche, Canada; Zensei Yakuhin, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 8 May 2011

Orzid




Orzid may be available in the countries listed below.


Ingredient matches for Orzid



Ceftazidime

Ceftazidime is reported as an ingredient of Orzid in the following countries:


  • Ethiopia

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Orzid in the following countries:


  • South Africa

International Drug Name Search